Latest Breaking News On - Guardant health contacts - Page 1 : comparemela.com

Guardant Health announces new data to be presented at 2023 Digestive Disease Week showcasing the potential of its blood-based technology to detect colorectal cancer

Guardant Health announces new data to be presented at 2023 Digestive Disease Week showcasing the potential of its blood-based technology to detect colorectal cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAmirali talasazDaniel chungAlex klebanSociety for surgery of the alimentary tractGuardant healthGuardant health incHarvard medical schoolGuardant health forwardProfessor of medicine at harvard medical schoolAmerican society for gastrointestinal endoscopyExchange commissionAmerican gastroenterological associationGuardant health contactsDigestive disease weekMassachusetts general hospital

Guardant Health (GH) and AnHeart Collaborate to Develop Guardant360 CDx and Guardant360 TissueNext

Guardant Health (GH) and AnHeart Collaborate to Develop Guardant360 CDx and Guardant360 TissueNext
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHelmy eltoukhyAlex klebanWeiqing wangJunyuan jerry wangMichael weistGuardant healthExchange commissionGuardant health incGuardant health forwardDrug administration breakthrough therapy designationGuardant health contactsEuropean unionAnheart therapeuticsTherapy designationGuardant reveal

Guardant Health, Inc : Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal blood test to help guide treatment decisions in colorectal cancer

Trial will evaluate use of circulating tumor DNA to guide chemotherapy treatment decisions following surgery for stage II-III colorectal cancer patients based on test results for minimal residual

United kingdomHelmy eltoukhyAlex klebanDavid cunninghamGuardant healthNational institute of health researchExchange commissionGuardant health incGuardant health contactsGuardant health forwardInstitute of cancer researchRoyal marsden cancer charityResearch councilFoundation trust on partGuardant revealRoyal marsden

Guardant Health and Susan G Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy

Guardant Health and Susan G Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Helmy eltoukhyAlex klebanSusang komenGuardant healthGuardant health incExchange commissionGuardant health contactsMission at susang komenWall streetGuardant revealVictoria wolodzko smartFinancial conditionAnnual reportHealth contacts

Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China

Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio of cancer tests to help advance drug development programs and their clinical trials SINGAPORE

United statesLing yangHelmy eltoukhyPrakash rajaAlex klebanLawrence wangGuardant healthPrnewswire guardant health incExchange commissionGuardant health forwardGuardant health contactsInternational agency for research on cancerAdicon holdingsAdicon holdings limitedChief financial officerGuardant reveal